BioCentury
ARTICLE | Financial News

InflaRx raises $51M follow-on

May 11, 2018 5:07 PM UTC

Inflammatory diseases company InflaRx N.V. (NASDAQ:IFRX) raised $51 million on May 3 through the sale of 1.5 million shares at $34 in a follow-on underwritten by J.P. Morgan, Leerink, BMO Capital Markets and SunTrust Robinson Humphrey...

BCIQ Company Profiles

InflaRx N.V.

BCIQ Target Profiles

Complement 5a (C5a)